FDA Grants Class II Status For Power Morcellator Containment Systems
This article was originally published in The Gray Sheet
The agency will require 510(k) clearance for the devices, which can be used to isolate tissue removed from the uterus during morcellation. However, labeling will need to state that the systems have not been proven to reduce the risk of cancer.
Register for our free email digests: